Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$39.03 – $68.08
14% from low
Exchange
OTC Link
OS
CHUGAI PHARMACEUTICAL
No one on the platform currently holds CHGCF.
No tracked institution reports a position in CHGCF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-12-31 | $66.0000 | |
| 2026-06-30 | $66.0000 | 2026-08-28 |
| 2025-12-31 | $72.0000 | 2026-03-27 |
| 2025-12-31 | $75.0000 | 2026-03-27 |
| 2025-06-30 | $50.0000 | 2025-08-28 |
| 2025-06-30 | $75.0000 | 2025-08-28 |
| 2024-12-31 | $57.0000 | 2025-03-28 |
| 2024-06-28 | $41.0000 | 2024-08-29 |
| 2023-12-29 | $40.0000 | 2024-03-29 |
No one on the platform has traded CHGCF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.40T | +12.3% | $312.40 | $294.84–$337.18 | 0.1× | 2 |
| 2027 | $1.54T | +10.1% | $362.07 | $341.72–$390.79 | 0.1× | 2 |
| 2028 | $1.68T | +9.1% | $411.01 | $387.91–$443.62 | 0.1× | 4 |
| 2029 | $1.93T | +14.9% | $484.60 | $457.36–$523.05 | 0.1× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-24 | $0.46 | $0.42 | -8.6% |
| 2026-04-24 | $0.42 | $0.44 | +5.6% |
| 2026-01-29 | $0.47 | $0.50 | +5.5% |
| 2025-10-24 | $0.50 | $0.52 | +2.4% |
| 2025-07-24 | $0.51 | $0.40 | -21.9% |
| 2025-04-24 | $0.34 | $0.39 | +15.9% |
| 2025-01-30 | $0.00 | $0.35 | +14707.5% |
| 2024-10-25 | $0.42 |
| $0.44 |
| +3.6% |
| +0.91% |
| $101.9B |
| — |
| HOCPYHOYA Corporation | $167.84 | +0.16% | $56.1B | — |
| IPSEYIpsen S.A. | $45.03 | +0.00% | $59.5B | — |
Source: Financial Modeling Prep · peers by sector/industry